Home › Transthyretin-Related Hereditary Amyloidosis › Illinois › Chicago
Transthyretin-Related Hereditary Amyloidosis clinical trials in Chicago, IL
3 studies for Transthyretin-Related Hereditary Amyloidosis are looking for participants at sites in and around Chicago (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
RecruitingObservational study
- Research Site, Chicago
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
RecruitingPhase 3
- John H. Stroger, Jr. Hospital of Cook County, Chicago
- University of Chicago - Medical Center, Chicago
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
RecruitingPhase 3
- Northwestern University, Chicago
Transthyretin-Related Hereditary Amyloidosis trials in other cities
- New York City, NY5 studies
- Los Angeles, CA5 studies
- Baltimore, MD4 studies
- San Diego, CA4 studies
- Durham, NC4 studies
- Dallas, TX4 studies
- Philadelphia, PA4 studies
- Portland, OR4 studies
- Boston, MA4 studies
- Houston, TX3 studies
- New Haven, CT3 studies
- St. Louis, MO3 studies
Other studies in Chicago
- Non-Small Cell Lung Cancer61 studies
- Breast Cancer59 studies
- Cancer (all types)51 studies
- Metastatic Cancer45 studies
- Prostate Cancer45 studies
- Lung Cancer41 studies
- Obesity41 studies
- Ovarian Cancer36 studies
- Colorectal Cancer34 studies
- Stroke34 studies
- Heart Failure31 studies
- Overweight29 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.